CClinicalTrials.gg
CompletedNCT04086563Updated Jun 8, 2021

Effects of Motor Imagery in Pain Modulation and Median Nerve Mechanosensitive in Healthy Patients

An interventional study of Action observation and Mirror therapy in Median Nerve Injury, sponsored by Universidad Rey Juan Carlos. Completed at 1 site in Spain. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-06-08.

Sponsored by Universidad Rey Juan Carlos · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

The aim of this study are 1) to determinate the effectiveness of motor imagery or strength training in differens aspects of pain modulation. 2) evaluate the functional improvement of the hand by a motor imagery protocol.

02

Conditions studied

  • Median Nerve Injury
03

In context

Lead sponsor

Universidad Rey Juan Carlos is the lead sponsor of 111 studies on the registry; 22 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Healthy

Exclusion criteria

Exclusion Criteria:

  • be under 18
  • any pathology which provoke pain.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
100 participants (actual)

Study arms

  • Experimental
    Action observation

    The patients will observe a 25 minutes clip of neurodynamic exercises of the hand.

    Other: Mirror therapy · Other: Neurodynamic exercises · Other: Strength

  • Experimental
    Mirror Therapy

    With a mirror glasses, the patients will execute neurodynamic movements of their non-dominant hand during 25 minutes.

    Other: Action observation · Other: Neurodynamic exercises · Other: Strength

  • Active comparator
    Strength Training

    Strength protocol for the dominant hand.

    Other: Action observation · Other: Mirror therapy · Other: Neurodynamic exercises

  • Experimental
    Neurodynamic exercise

    Active neurodynamic exercises for the dominant hand.

    Other: Action observation · Other: Mirror therapy · Other: Strength

Interventions

  • OtherAction observation

    look at a clip of a hand doing neurodynamic exercises.

  • OtherMirror therapy

    With a mirror glasses on, do the neurodynamic exercises with the non-dominant hand while the patient is looking at the dominant hand

  • OtherNeurodynamic exercises

    active movement of the dominant hand. Do neurodynamic exercises.

  • OtherStrength

    Execute a short strength training for the dominant hand

06

What researchers measure

Primary outcomes

  1. Conditioned pain modulation

    Diffused noxious inhibitory control system will be measure with tourniquet test

    Time frame: Change from baseline at 2 weeks

  2. Pressure pain threshold

    Three consecutive trials of pressure pain threshold on the active trigger point at a rate of 1 kg/sec at intervals of 30 seconds were conducted.

    Time frame: Change from baseline at 2 weeks

  3. Cold hyperalgesia

    10 seconds of a cold pack and after that, rating the pain from 0 to 10

    Time frame: Change from baseline at 2 weeks

  4. Neural mechanosensitive

    Upper Limb Neurodynamic test 1 (ULNT1)

    Time frame: Change from baseline at 2 weeks

Secondary outcomes

  1. Strength_grip

    grip strength without pain

    Time frame: Change from baseline at 2 weeks

  2. Imagine movement capacity

    testing the capacity of imagine that their own body is movement. Movement Imagery Questionnaire-Revised (MIQ-R questionaire). top score 56 and bottom score 8. The higher values indicates a better outcome.

    Time frame: Change from baseline at 2 weeks

  3. Psychological factors_Anxiety

    State Trait Anxiety Inventory (STAI-T). Top score 60 and bottom score 0. The higher values indicate worst outcomes.

    Time frame: Change from baseline at 2 weeks

  4. Psychological factors_Depression

    Beck Depression Inventory (BDI-II). the scores goes from 0 to 63. The higher values indicate worst outcomes. Beck Depression Inventory (BDI-II) Beck Depression Inventory (BDI-II)

    Time frame: Change from baseline at 2 weeks

  5. Psychological factors_Kinesiophobia

    Tampa Scale for Kinesiophobia. Total scores goes from 11 to 44.The higher values indicate worst outcomes.

    Time frame: Change from baseline at 2 weeks

07

Study locations

1 site
  • Universidad Rey Juan Carlos
    Alcorcón, Madrid 28922, Spain
08

References and documents

Publications

  • Matesanz-Garcia L, Caceres-Pajuelo JE, Cuenca-Martinez F, La Touche R, Goicoechea-Garcia C, Fernandez-Carnero J. Effects of neural mobilizations through movement representation techniques for the improvement of neural mechanosensitivity of the median nerve region: a randomized controlled trial. Somatosens Mot Res. 2021 Dec;38(4):267-276. doi: 10.1080/08990220.2021.1964463. Epub 2021 Aug 17. PubMed 34404324 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 8, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04086563
Lead sponsor
Universidad Rey Juan Carlos
Responsible party
Josue Fernandez Carnero (Principal Investigator, Universidad Rey Juan Carlos) — Principal investigator
First posted
Sep 11, 2019
Start date
Sep 8, 2019
Primary completion
Jan 31, 2020
Completion
Feb 25, 2020
Last update
Jun 8, 2021

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion